Gonadal steroids affect a wide variety of functions in the mammalian brain
ranging from the regulation of neuroendocrine systems and the modulation of
behavior to the stimulation of differentiation and plasticity of distinct
neuronal populations and circuits. The last decades have also demonstrated
that estrogen serves as a neuroprotective factor for distinct neurodegenera
tive disorders. Such neuroprotective effects of estrogen are most obvious f
or Parkinson's and Alzheimer's disease. Despite this knowledge, little is k
nown about the mechanisms and cellular targets by that estrogen might elici
t its protective influence. In the past, we have intensively studied the ef
fects of estrogen on midbrain dopaminergic neurons which represent the most
affected cell population juring Parkinson's disease. These studies were ma
inly performed on developing dopaminergic cells and revealed that estrogen
is an important regulator of plasticity and function of this neuronal pheno
type. Precisely, we found that dopaminergic neurons are direct targets for
estrogen and that estrogen stimulates neurite extension/branching and the e
xpression of tyrosine hydroxylase, the key enzyme in dopamine synthesis. To
gether with other in vivo studies, we might draw the conclusion that estrog
en is required for the plasticity and activity of the developing and adult
nigrostriatal system. The presence of the estrogen-synthesizing enzyme arom
atase within the nigrostriatal system further supports this idea. Surprisin
gly, estrogen effects on nigrostriatal cell function are not only transmitt
ed by classical nuclear estrogen receptors but also depend on nonclassical
estrogen actions mediated through putative membrane receptors coupled to di
verse intracellular signaling cascades. In the future, it has to be elucida
ted whether nonclassical mechanisms besides genomic actions also contribute
to estrogen-mediated neuroprotection in the adult CNS.